Table 1 Clinicopathological characteristics of responders and non-responders

From: Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma

 

IFNAR2-positive

IFNAR2-negative

 

Responders ( n =10)

Non-responders ( n =10)

Non-responders ( n =10)

P -value

Age (year)

   

NS

 <60

6

7

5

 

60

4

3

5

 

Sex

   

NS

 Male

9

9

9

 

 Female

1

1

1

 

HBV infection

   

NS

 Present

6

8

7

 

 Absent

4

2

3

 

HCV infection

   

0.0180

 Present

7

1

3

 

 Absent

3

9

7

 

Child-pugh score

   

NS

 A

7

7

5

 

 B, C

3

3

5

 

Liver cirrhosis

   

NS

 Present

4

7

3

 

 Absent

6

3

7

 

α-fetoprotein (ng ml−1)

   

NS

 <300

5

1

3

 

300

5

9

7

 

Tumour size (cm)

   

NS

 <5

2

3

2

 

5

8

7

8

 

Histological grade

   

NS

 Moderately differentiated

1

0

0

 

 Poorly differentiated

9

8

9

 

 Undifferentiated

0

2

1

 

IFNAR2 expression

   

<0.0001

 0

0

0

10

 

 1

8

10

0

 

 2

2

0

0

 
  1. HBV=hepatitis B virus; HCV=hepatitis C virus; IFNAR2=type I interferon receptor 2.